Critical gases for critical issues: CO2 technologies for oral drug delivery.
In recent years, CO2-based technologies have gained considerable interest in the pharmaceutical industry for their potential applications in drug formulation and drug delivery. The exploitation of peculiar properties of gases under supercritical conditions has been studied in the last 20 years with mixed results. Promising drug-delivery technologies, based on supercritical CO2, have mostly failed when facing challenges of industrial scaleability and economical viability. Nevertheless, a 'second generation' of processes, based on CO2 around and below critical point has been developed, possibly offering technology-based solutions to some of the current issues of pharmaceutical development. In this review, we highlight the most recent advancements in this field, with a particular focus on the potential of CO2-based technologies in addressing critical issues in oral delivery, and briefly discuss the future perspectives of dense CO2-assisted processes as enabling technologies in drug delivery.
SiTec PharmaBio, Baldiri Reixac 10, 08028 Barcelona, Spain.
Hana
H
Danan
Pierandrea
P
Esposito
D000284:Administration, Oral; D000818:Animals; D002245:Carbon Dioxide / Q000737:chemistry*; D002626:Chemistry, Pharmaceutical; D004337:Drug Carriers; D005740:Gases; D006801:Humans; D050997:Nanomedicine; D053758:Nanoparticles; D004364:Pharmaceutical Preparations / Q000008:administration & dosage* / Q000737:chemistry; D013678:Technology, Pharmaceutical / Q000379:methods
D004337:Drug Carriers; D005740:Gases; D004364:Pharmaceutical Preparations; D002245:Carbon Dioxide